The U.S. should review Chinese biotech firm WuXi AppTec and its affiliate WuXi Biologics for sanctions, a bipartisan group of lawmakers told top Biden administration officials on Monday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
